论文部分内容阅读
最近在卫生部召开的《全国中药炮制规范》编委会议上,对该书中收载的某些药材品种及其来源,与《中国药典1985年版》规定有所不同,如槐花与槐米等存有原则争议。85版药典将槐花与槐米分列为两个品种,理由为二者芦丁成分含量多少不同,故规定槐花的芦丁含量不得少于8.0％,槐米的芦丁含量不得少于20.0％,另外,槐花比槐米价格便宜,且易收购。但药典中的用法用量等各项规定完全相同,而全国炮制规范则只收载槐花一种,其药材来源为未开放的花蕾,理由为槐米未见本草记载,全国统编教材《中药学》
Recently, at the meeting of the editorial board of the National Code of Chinese Medicine Processing, convened by the Ministry of Health, some varieties and origins of certain medicinal herbs contained in the book are different from those in the 1985 edition of the Chinese Pharmacopoeia, such as silk flowers and glutinous rice. There are principle disputes. The 85th Pharmacopoeia classifies Flos Sophorae and glutinous rice into two varieties. The reason is that the content of rutin in the two is different. Therefore, it is required that the content of rutin in Flos Sophorae should not be less than 8.0%, and the content of Rutin in japonica rice should not be less than 20.0%. In addition, glutinous rice is cheaper than glutinous rice and easy to acquire. However, the pharmacopoeia has the same usage, dosage, and other provisions, and the national concocting standard only includes one type of thistle flower. The source of the medicinal material is the unopened flower bud. The reason is that the glutinous rice is not recorded in the Chinese materia medica. Pharmacy